A Bill to make provision to incentivise research and investment into the treatment of rare types of cancer; and for connected purposes.
The Rare Cancers Bill is designed to spur research and investment into treatments for rare cancers. It began in the House of Commons and has moved to the House of Lords, where it is currently at its third-reading stage; the sponsor is Dr Scott Arthur (Labour (Co-op)).
The bill is in the Lords at the third-reading stage. If it progresses, it would continue through the Lords and then potentially return to the Commons for consideration of amendments before final approval.
Generated 21 February 2026
On 11 February the Bill reached committee stage in the Lords.
However, no changes were suggested to the bill so the bill goes directly to third reading. This procedure is known as "order of commitment discharged".
What happens next?
Third reading takes place on 27 February when final amendments can be made.
No recorded votes for this bill yet.
